<i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs
The aim of review. To demonstrate value of H. pylori eradication therapy in patients for prophylaxis and treatment of nonsteroid antiinflammatory drugs (NSAID)- induced gastropathies.Key points. NSAID and H. pylori act as independent risk factors of ulcer development. Eradication therapy is the majo...
Saved in:
Main Authors: | V. T. Ivashkin, T. L. Lapina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2012-11-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1336 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
by: Elif Gram Bacaksız, et al.
Published: (2022-05-01) -
How to Make the Right Choice of Proton Pump Inhibitor for Patients with Gastroesophageal Reflux Disease?
by: Yu. V. Evsyutina
Published: (2023-06-01) -
Investigating Non-steroidal Anti-Inflammatory Drugs as Potential Cancer Adjuncts: A Novel Approach to Cancer Therapy
by: Sadaf Alam, et al.
Published: (2025-02-01) -
Investigating Non-steroidal Anti-Inflammatory Drugs as Potential Cancer Adjuncts: A Novel Approach to Cancer Therapy
by: Sadaf Alam, et al.
Published: (2025-02-01) -
Pantoprazole – safety in drug-drug interaction
by: E. V. Shikh, et al.
Published: (2012-09-01)